According to Fortune Business Insights, the global Stents Market size was valued at USD 15.44 billion in 2025. The market is projected to grow from USD 16.02 billion in 2026 to USD 21.54 billion by 2034, exhibiting a CAGR of 3.77% during the forecast period (2026–2034). Increasing cardiovascular disease prevalence, growing demand for minimally invasive procedures, and advancements in drug-eluting and bioresorbable stents are contributing to steady market expansion.
The global Stents Market is experiencing consistent growth due to the increasing adoption of interventional medical procedures. Hospitals, specialty clinics, and ambulatory surgery centers are major end users of stent technologies.
Coronary stents represent the largest product type, accounting for approximately 45% of the market in 2025. North America dominates the global industry with a 38% revenue share, supported by advanced healthcare infrastructure and widespread adoption of cardiovascular interventions.
Manufacturers are investing in research and development to introduce innovative stent designs that improve flexibility, biocompatibility, and long-term clinical performance.
For detailed market insights: https://www.fortunebusinessinsights.com/industry-reports/stents-market-100672
Several emerging trends are transforming the Stents Market landscape.
Increasing Adoption of Drug-Eluting Stents: Advanced drug-eluting technologies are gaining popularity because they help minimize restenosis and improve long-term vessel patency.
Growing Interest in Bioresorbable Stents: Bioresorbable vascular scaffolds provide temporary structural support and gradually dissolve after healing, potentially reducing complications associated with permanent implants.
Development of Bioengineered Stents: Manufacturers are developing specialized surface coatings that encourage endothelial healing and reduce inflammatory responses.
Advancements in Imaging-Guided Procedures: Modern imaging technologies are improving stent placement accuracy, particularly in complex vascular anatomies.
These developments are encouraging healthcare providers to adopt next-generation stent technologies.
The increasing incidence of coronary artery disease, peripheral vascular disorders, diabetes, and hypertension is a major driver of market growth. Aging populations and sedentary lifestyles are contributing to higher demand for cardiovascular interventions.
Stent-based treatments are increasingly preferred over traditional open surgical procedures in suitable cases because they can offer shorter recovery periods and reduced hospitalization requirements.
Innovations in drug-eluting coatings, biodegradable materials, and ultra-thin stent structures are improving device performance and expanding clinical applications.